Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Site search
Search
Menu
Subscribe
Home
Promote Your Event
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscription Services
Local Weather
News
Local News
Sports
Entertainment
Obituaries
Local Events
Photos
Videos
e-Edition
Classifieds
Place an ad
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
bioAffinity Technologies, Inc. - Common Stock
(NQ:
BIAF
)
1.820
UNCHANGED
Streaming Delayed Price
Updated: 3:59 PM EDT, Jun 2, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
7,846
Open
1.780
Bid (Size)
1.710 (1)
Ask (Size)
1.970 (1)
Prev. Close
1.820
Today's Range
1.780 - 1.890
52wk Range
1.310 - 15.55
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
bioAffinity Technologies Presents Research Findings at CYTO 2023
May 22, 2023
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies Reports First Quarter 2023 Financial Results
May 15, 2023
From
bioAffinity Technologies, Inc.
Via
Business Wire
Performance
YTD
+16.67%
+16.67%
1 Month
-3.70%
-3.70%
3 Month
+4.00%
+4.00%
6 Month
-38.10%
-38.10%
1 Year
-78.07%
-78.07%
More News
Read More
bioAffinity Technologies Names Michael Dougherty as Chief Financial Officer
May 01, 2023
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies Presents at Cleveland Clinic Lung Cancer Symposium
April 25, 2023
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies to Ring Nasdaq Closing Bell Today
April 05, 2023
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies Reports Fourth Quarter and Full Year 2022 Financial Results
March 31, 2023
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies Announces Publication of Peer-Reviewed Paper on Proprietary Beads Used in CyPath® Lung for Noninvasive Detection of Early-Stage Lung Cancer
March 28, 2023
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies to Report Fourth Quarter 2022 Financial Results on March 31, 2023
March 24, 2023
From
bioAffinity Technologies, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Friday's Pre-Market Session
February 17, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
February 14, 2023
Via
Benzinga
bioAffinity Technologies Appoints Julie Anne Overton Director of Corporate Communications
February 13, 2023
From
bioAffinity Technologies, Inc.
Via
Business Wire
Dow Rises 80 Points; Altamira Therapeutics Shares Plunge
January 24, 2023
Via
Benzinga
Why Baudax Bio Shares Are Trading Higher By 60%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
January 24, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
January 24, 2023
Via
Benzinga
Dow Edges Higher; Crude Oil Down 1%
January 24, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
January 24, 2023
Via
Benzinga
bioAffinity Technologies Announces Publication of Results of Clinical Trial in Peer-Reviewed Journal Respiratory Research
January 24, 2023
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies Announces Notice to Award U.S. Patent Protecting Novel Compounds for Specific Delivery of Cancer Treatments
January 04, 2023
From
bioAffinity Technologies, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Wednesday's After-Market Session
December 28, 2022
Via
Benzinga
bioAffinity Technologies Expands Diagnostic Division with Promotions and New Hires to Strengthen Clinical Bench
December 15, 2022
From
bioAffinity Technologies, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Friday's Intraday Session
December 09, 2022
Via
Benzinga
bioAffinity Technologies Presents Proprietary Cancer Therapeutic Research at Joint ASCB-EMBO Meeting
December 01, 2022
From
bioAffinity Technologies, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Wednesday's After-Market Session
November 30, 2022
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
November 21, 2022
Via
Benzinga
bioAffinity Technologies Reports Third Quarter 2022 Financial Results and Provides Business Update
November 14, 2022
From
bioAffinity Technologies, Inc.
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.